Dirk Jan van Veldhuisen is Professor of cardiology and has served as Chairman of the department of Cardiology at the University Medical Center Groningen since 2001. He has had his training in Internal Medicine and Cardiology in Rotterdam and Groningen, the Netherlands.
Professor van Veldhuisen has a long-standing interest in Clinical and Experimental Heart Failure. Particular interests are the treatment of heart failure, including both pharmacologic and non-pharmacologic (device) interventions, neurohormonal activation, genetics, arrhythmias, and comorbidities, such as renal dysfunction/anemia .
He is an editorial board member of of a number of journals and served as national Coordinator/Member of Steering Committee of >35 Heart Failure Trials, and was Principal Investigator of 8 of them.He has served as chairman (1997-2002) and Member of the Working Group of Heart Failure, Netherlands Society of Cardiology and received a large number of Research Grants from the Netherlands Heart Foundation, including the established Investigator grant in 1997.
Professor van Veldhuised is a member of Heart Failure Association of the ESC, and was a member of the Task Force on the Diagnosis and Treatment of Heart Failure 2008 and the ESC Guidelines Update 2010. He was also a member of the Task Force for the ESC Guideline on Ventricular Arhythmias and Sudden Cardiac Death in 2015. From 2010-2015, he served as the Editor-in-Chief of European Journal of Heart Failure.He has authrored more that 1000 publications and his Hirsch-index is 116. He has been the promotor of >75 PhD fellows in the last 20 years.
Digoxin Evaluation in Chronic heart failure: Investigational Study In Outpatients in the Netherlands: DECISION
Epicardial fat can cause heart failure with preserved ejection fraction.
Facilitate personalized therapies in patients with heart failure